Growing community of inventors

San Antonio, TX, United States of America

Bismarck Campos

Average Co-Inventor Count = 5.71

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Bismarck CamposStanton F McHardy (7 patents)Bismarck CamposGraham Beaton (4 patents)Bismarck CamposHua-Yu Leo Wang (4 patents)Bismarck CamposAmbrosio Lopez, Jr (4 patents)Bismarck CamposMichael Wade Tidwell (3 patents)Bismarck CamposDonald M Maxwell (3 patents)Bismarck CamposRichard Michael Corbett (3 patents)Bismarck CamposChristopher J Bemben (3 patents)Bismarck CamposFabio C Tucci (1 patent)Bismarck CamposSatheesh Babu Ravula (1 patent)Bismarck CamposFrancisco Xavier Ruiz (1 patent)Bismarck CamposStanton F Mchardy (0 patent)Bismarck CamposSatheesh B Ravula (0 patent)Bismarck CamposFrancisco Xavier Iii Ruiz (0 patent)Bismarck CamposBismarck Campos (7 patents)Stanton F McHardyStanton F McHardy (23 patents)Graham BeatonGraham Beaton (13 patents)Hua-Yu Leo WangHua-Yu Leo Wang (5 patents)Ambrosio Lopez, JrAmbrosio Lopez, Jr (4 patents)Michael Wade TidwellMichael Wade Tidwell (8 patents)Donald M MaxwellDonald M Maxwell (6 patents)Richard Michael CorbettRichard Michael Corbett (4 patents)Christopher J BembenChristopher J Bemben (3 patents)Fabio C TucciFabio C Tucci (20 patents)Satheesh Babu RavulaSatheesh Babu Ravula (11 patents)Francisco Xavier RuizFrancisco Xavier Ruiz (5 patents)Stanton F MchardyStanton F Mchardy (0 patent)Satheesh B RavulaSatheesh B Ravula (0 patent)Francisco Xavier Iii RuizFrancisco Xavier Iii Ruiz (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Curtana Pharmaceuticals, Inc. (4 from 5 patents)

2. Southwest Research Institute (3 from 1,118 patents)


7 patents:

1. 12145913 - Inhibition of Olig2 activity

2. 11691951 - Inhibition of Olig2 activity

3. 11685722 - Inhibition of Olig2 activity

4. 11242323 - Inhibition of OLIG2 activity

5. 9169220 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

6. 8772345 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

7. 8653108 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…